Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NANOSONICS LIMITED Director's Dealing 2019

Feb 6, 2019

65405_rns_2019-02-06_7f872436-bf13-4093-ae2a-fb5670ce647d.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Nanosonics Limited ABN 11 095 076 896

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Mr Michael Kavanagh
Date of last notice 30 November 2018

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest a) Indirect Interest
b) Indirect Interest
c) Indirect Interest
d) Direct Interest
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
a) Performance
Rights
held
in
the
Nanosonics Employee Share Option
Plan.
b) Performance
Rights
held
in
the
Nanosonics Omnibus Equity Plan
c) Options held in the Nanosonics Omnibus
Equity Plan
Date of change 7 February 2019
No. of securities held prior to change a) 206,882 Performance Rights held in the
Nanosonics Employee Share Option
Plan.
b) 146,387 Performance Rights held in the
Nanosonics Omnibus Equity Plan.
c) 551,730 Options held in the Nanosonics
Omnibus Equity Plan
d) 1,328,363 (Direct) Ordinary Shares
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class a) Performance Rights
b) Performance Rights
c) Options
d) Ordinary Shares
Number acquired 20,900 Performance Rights
286,885 Options
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
N/A
No. of securities held after change a) 206,882 Performance Rights held in the
Nanosonics Employee Share Option
Plan.
b) 167,287 Performance Rights held in the
Nanosonics Omnibus Equity Plan.
c) 838,615 Options held in the Nanosonics
Omnibus Equity Plan
d) 1,328,363 (Direct) Ordinary Shares
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back
Issue of 20,900 Performance Rights and
286,885 Options under the terms and
conditions of the Nanosonics Omnibus
Equity Plan.
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

Director: Mr. Michael Kavanagh Date: 7 February 2019

  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3